CTLA4 and osteosarcoma: Similarly, when osteosarcoma cells were incubated with recombinant B7-1 or B7-2 ligands, CTLA-4 directed caspase-dependent apoptosis in these cells, further exploring its sensitivity to be targeted by anti-cancer agents.